Form 4 for ASH ASHLAND INC.
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-03 · accession 0001127602-22-003300 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-04 | 2022-02-03 | ASH | WANG XIAOLAN | SVP, Gen Mgr, Personal Care | D - Sale to Iss | $96.03 | -269.39 | 0 | -100% | -$25.9K |
| D | 2022-02-04 | 2022-02-03 | ASH | WANG XIAOLAN | SVP, Gen Mgr, Personal Care | M - OptEx | — | +269.39 | 269.39 | New | — |
| D | 2022-02-04 | 2022-02-03 | ASH | WANG XIAOLAN | SVP, Gen Mgr, Personal Care | M - OptEx | — | -269.39 | 269.39 | -50% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-03 | D | D | 269.39 | $96.03 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-03 | M | A | 269.39 | — | 269.39 | D | — | — | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. |
| 3 | Derivative | Restricted Stock Equivalents | 2022-02-03 | M | D | 269.39 | — | 269.39 | D | — · — to — | 269.39 Common Stock | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. (F2) Grant of Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. |